Real-time enrollment status for this hereditary angioedema clinical trial
Current Status
Completed
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06343779 |
| Recruiting Status | Completed |
| Condition | Hereditary Angioedema |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Pharvaris Netherlands B.V. |
| Last Updated on CT.gov | November 21, 2025 (Nov 21, 2025) |
As of March 2, 2026: Clinical trial NCT06343779 is currently completed participants. This clinical trial study for hereditary angioedema is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Pharvaris Netherlands B.V.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06343779 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06343779 was last updated Nov 21, 2025 (November 21, 2025). HelloStudys verifies this status automatically.